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 Abstract 
Zilpaterol hydrochloride (ZH) is a growth promotant that is approved for use in finishing 
cattle to improve growth performance and increase lean tissue accumulation. Little is known 
about the combined effects of ZH with anabolic steroid hormone implants. There is also little 
published data on the effect these growth promotants have on genes that play a role in skeletal 
muscle synthesis and degradation. Therefore, two separate studies were conducted to address 
these issues. The first study evaluated the effects of ZH and the steroid implant Revalor-S (RS) 
on animal performance and skeletal muscle gene expression in feedlot steers. Four treatments 
were used to analyze the effects of RS implanted 58 days before ZH, which was fed for 30 days 
with a 3 day withdrawal. It was determined that ZH and RS additively contribute to improved 
live and carcass performance; however these compounds had different effects on the abundance 
of the receptors for ZH as well as the abundance of myosin heavy chain (MHC) mRNA in 
skeletal muscle of feedlot steers. It was also determined that ZH can cause a transition in the 
abundance of MHC mRNA isoforms in skeletal muscle that are available for the translation of 
larger, faster, more glycolytic fiber types of MHC. The second study evaluated the effects of two 
types of anabolic steroid hormones on myosin heavy chain gene expression. Four treatments 
were used to measure the effects of trenbolone acetate (TBA) and estradiol (E2) on performance 
and the amount of MHC mRNA in skeletal muscle of finishing steers. It was determined that 
anabolic steroid implants improve live animal performance, however there was no alteration in 
the abundance of MHC mRNA in skeletal muscle of feedlot steer for 28 days after implantation; 
however there was an increase in intermediate fiber type IIA of MHC mRNA in skeletal muscle 
with increasing days on feed. From these studies we concluded that ZH and anabolic steroids do 
have an effect on growth performance; however they may differ in the distinct mechanism of 
action utilized to enhance lean tissue deposition in feedlot steers. 
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Introduction 
 One of the major factors involved in profitability in the beef cattle industry is the cost 
associated with animal weight gain. Due to this, there have been advancements made in the 
production of exogenous compounds that can be administered to cattle to improve the efficiency 
with which an animal can convert energy consumed into body mass. Furthermore, these 
compounds have the capability to alter the composition of the weight accumulation within the 
animal. Special attention has been given to the lean tissue involved in this weight gain in the beef 
cattle industry. With current feed cost at record high levels, the cattle industry needs to utilize the 
FDA-approved technologies available for improved growth efficiency. 
 Currently, there are two classes of growth promoting agents that are approved for use in 
the cattle finishing industry that have been shown to stimulate lean tissue deposition. The most 
widely utilized growth promoters are anabolic steroids, which have been approved and widely 
used for over 50 years. The other type of growth promoting agent is phenethanolamines, also 
known as β-adrenergic agonists (βAA). These synthetic compounds have only been utilized with 
finishing cattle in the United States for the last 5 years, and they elicit similar biological 
responses as anabolic steroids, but this is achieved through pathways that appear to differ from 
those of anabolic steroids. This review will look at the effects of skeletal muscle development 
with different types of growth promoters, and how their combined use may affect performance 
and the composition of growth in finishing beef cattle. 
Characteristics of Postnatal Skeletal Muscle 
 Skeletal muscle is a specialized tissue within mammalian species that has various 
functions, and it is of great interest in meat producing livestock systems. The structural 
components of muscle function within mammals to generate contractile energy as well as being 
involved in many other biological functions. A unique characteristic of skeletal muscle is that the 
primary cellular unit consists of individual muscle fibers. The numbers of these multinucleated 
muscle fibers, as well as the nuclei, are post-mitotic or fixed at birth. They do however have the 
post-natal capability to increase in size by means of hypertophic growth. It has been shown that 
DNA synthesis precedes mitosis (Messier and LeBlond, 1960). Furthermore, hypertrophic 
growth is directly related to the DNA accumulation within the fiber that is necessary to increase 
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the size of the fiber by the transcription of DNA to RNA and subsequently the translation of 
protein (Trenkle et al., 1978). Because the number of nuclei present on each fiber is fixed, then 
the amount of DNA available for growth and protein synthesis is limited. However, during 
growth these fibers do increase in the amount of DNA accumulated. From 60 to 90% of the DNA 
found in the muscle fiber is accumulated during the growth of the animal, postnatally (Allen et 
al., 1979). From this confounding evidence, a specialized type of myogenic cell was discovered. 
Satellite cells are the source of this postnatal DNA accumulation. 
Satellite Cells 
 Satellite cells are mononucleated cells that are located between the basal lamina and 
sarcolemma of muscle fibers (Mauro, 1961). Moss and LeBlond (1970) observed, by use of 
electron microscope, two distinct types of nuclei located on the muscle fiber. These nuclei had 
distinct physical features and differed in their location relative to the sarcolemma of the fiber. 
Moss and LeBlond (1970) conducted a study where mice were injected with 3H-thymidine and 
sacrificed at intervals from 1 to 72 hours later. From radioautograph results, there was no 
incorporation of 3H-thymidine in the true muscle nuclei 1 hour after injection, which suggests 
that they are not dividing. The satellite cells were labeled 1 hour after the injection, which 
suggests that they were synthesizing DNA and able to divide. Another interesting result they 
found was the number of labeled satellite cells decreased over time, and the number of labeled 
true muscle nuclei increased over time. From this it was determined that satellite cells can divide 
and incorporate into existing muscle fiber (Moss and LeBlond, 1970). However, once the 
satellite cell has incorporated into the fiber, they terminally lose their ability to proliferate (Moss 
and LeBlond, 1971). However, if all of the satellite cells were to incorporate and lose their 
ability to proliferate, hypertophic growth would not be able to continue throughout the animal’s 
life. In fact, one half of the daughter cells from satellite cells that had proliferated were able to 
incorporate into existing muscle fibers, and the other half of the non-incorporated daughter cells 
was able to continue proliferating (Cardasis and Cooper, 1975). These non-incorporated satellite 
cells are able to enter a state of quiescence or G0 of the cell cycle (Cardasis and Copper, 1975). 
This process provides a reserve of satellite cells for injury repair as well as additional growth as 
an animal progresses toward maturity. This poses a challenge in optimizing skeletal muscle 
growth in meat producing animals as they progress toward maturity. However, the obligatory 
role of satellite cells in acute muscle hypertrophy has been an issue of dispute. 
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 There is continued controversy over the hypothesis that hypertrophic growth can take 
place without incorporation of more satellite cell DNA into the existing muscle fiber. This 
hypothesis rests on the concept that the muscle fiber can increase the efficiency of the DNA 
already present to transcribe RNA and subsequently translate more protein. The DNA unit is the 
ultimate limiting factor for this process, therefore any hypertrophy independent of additional 
DNA will eventually reach a limit to the growth potential of the myofiber nuclei unless more 
DNA becomes available. This becomes a more pressing issue as an animal reaches a more 
mature age, because the number of satellite cells could be affected by age. Approximately 30% 
of the muscle nuclei are satellite cells in a newborn, however that amount drops as low as 2 to 
10% in mature animals, which shows that the actual number of satellite cells decreases with age 
(Cardasis and Cooper, 1975).  Furthermore, if exogenous compounds are capable of either 
promoting growth with or without satellite cell stimulation, research could be implemented to 
elucidate the extent of satellite cell’s obligatory role in muscle development. Therefore any 
factors that affect satellite cells could be key elements in optimizing growth in cattle, especially 
near maturity. 
Growth Factors 
 There are various transcription and growth factors that play a part in moderating the 
activity of satellite cells. The primary growth factor known to activate quiescent satellite cells is 
hepatic growth factor (HGF). It was determined that HGF is present in normal adult skeletal 
muscle and is capable of activating satellite cells (Tatsumi et al., 1998). A study by Allen et al. 
(1995) found that when HGF was exposed to satellite cells in culture, the lag time before 
quiescent cells enter the cell cycle was significantly shortened. It was also found that quiescent 
satellite cells express mRNA for c-met (Allen et al., 1995), which is the receptor for the ligand 
HGF (Bottaro et al., 1991). Another important determinant of satellite cell fate is the Notch 
signaling pathway. The proliferative expansion and myogenic lineage progression of quiescent 
satellite cells is regulated and maintained by the Notch signaling pathway (Conboy and Rando, 
2002). The activation of Notch-1 ligand, Delta, is one of the first changes associated with 
satellite cell activation, followed by the up regulation of Numb, an antagonist of Notch-1. 
Increased Numb expression leads to the expression of myogenic regulatory factors, desmin and 
Pax-7, which are indicators of proliferation and commitment of satellite cells to a myoblast cell 
fate (Conboy and Rando, 2002). 
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 Other factors affect the proliferation and differentiation of activated satellite cells. In an 
in vitro study conducted by Greene and Allen (1991), bovine satellite cells were cultured and 
exposed to basic (b) FGF, IGF-I, and TGF-β to evaluate their effect on satellite cells. When 
individually administered, the bFGF was found to stimulate proliferation, but inhibit 
differentiation. The IGF-I had no effect on proliferation, but stimulated differentiation, where as 
TGF-β inhibited both proliferation and differentiation. They further analyzed the effects on 
satellite cells when administered in combination. The maximum stimulation of proliferation 
occurred in the presence of bFGF and IGF-I, but there was no effect on differentiation. When 
bFGF was in the presence of TGF-β proliferation was stimulated, but differentiation was 
inhibited (Greene and Allen, 1991). One member of the TGF-β superfamily that is responsible 
for negative regulation of skeletal muscle is myostatin (McPherron et al., 1997). Embryonic 
mutations causing the inactivity of the myostatin gene lead to the condition known as double 
muscling in cattle (McPherron and Lee, 1997). This data suggests that these growth factors may 
play a critical role in regulating bovine satellite cell activity, and interaction of these growth 
factors may also play a role in that activity.  
Myosin Heavy Chain Isoform 
 Myosin is the most abundant protein present in striated muscle cells, comprising 
approximately 25% of the total protein pool (review by Baldwin and Haddad, 2001). Myosin 
serves as the backbone of the sarcomeric structure. It is also an enzyme that utilizes ATP and 
generates movement by binding with another sarcomeric protein, actin. This chemical energy is 
the force that generates a muscle contraction and enables physical body motion. As functional 
demands on muscle change, muscle fibers have the capacity to change their overall metabolism 
and contractility in response to various stimuli (Pette and Staron, 2000). Certain conditions of 
altered neuromuscular activity, mechanical loading, and hypothyroidism can cause MHC 
isoforms to transition from fast-to-slow or slow-to-fast fiber types (Pette and Staron, 2000). 
 The four isoforms of MHC that are predominantly found in different proportions within 
adult skeletal muscles of various mammalian species are MHC types I (also referred to as 
β/slow), IIA, IIX, and IIB (Schiaffino and Reggiani, 1996). Differences in sequencing of the loop 
1 and loop 2 regions of MHC isoforms have been found responsible for functional differences of 
MHC fibers (Chikuni et al., 2004). The loop 1 sequence is related to the rate of ADP release and 
affects ATPase activity (Sweeny et al, 1998; Chikuni et al., 2004). Comparing bovine and 
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porcine MHC, the major diversity in the loop 1 region was the differences between the fast and 
slow type isoforms (Weiss et al., 1999; Chikuni et al., 2002). The loop 2 region, however, has 
different functional aspect. The structure of the myosin head domain indicates that the loop 2 
region acts as an actin-binding site (Rayment et al., 1993), and sequence substitutions on the loop 
2 region can cause changes in ATPase activity (Ueda et al., 1994). Substitutions on the loop 2 
region might tune the rate-limiting step in the actin-activated ATPase cycle (Spudich, 1994), and 
be a major determinant of Vmax of the ATPase activity (Ueda et al., 1994). The sequence of the 
loop 2 region is different among all isoforms of MHC in cattle, as well as in humans and pigs 
(Weiss et al., 1999; Chikuni et al., 2001, 2002). These studies imply that the functional 
properties vary between fiber type and the bovine myosin can differ from porcine myosin within 
the same isoform or fiber type (Chikuni et al., 2004). An example of this the MHC type IIB 
isoform that is present in porcine muscle, but whose presence is questioned in cattle muscle. 
Recent findings have challenged the existence of type IIB MHC isoform in bovine skeletal 
muscle tissue, and have determined that no type IIB MHC mRNA could be detected in adult 
skeletal muscle RNA of cattle (Chikuni et al., 2004), however there is type IIB MHC fibers 
found only in specialized extraocular muscles in cattle (Toniolo et al., 2005). 
In regard to growth of meat producing animals, performance has been related to muscle 
fiber type composition in pigs (Sosnicki, 1987). Data shows that rats selected for rapid postnatal 
weight gain have more fast-contracting fibers (Swatland and Cassens, 1972). Furthermore, 
muscle from animals with certain genetic anomalies such as; double-muscled cattle, callipyge 
sheep, and halothane-positive pigs have been shown to have a greater proportion of fast, 
glycolytic muscle fibers (Lefaucheur and Gerrard, 2000). In contrast, domestic pig studies 
determined there was no evidence of differences in muscle fiber type composition due to 
selection for high lean growth (Karlsson et al., 1993; Larzul et al., 1997). Other studies further 
determined that induced muscle fiber hypertrophy observed with growth hormone had no effect 
on muscle fiber type (Beermann et al., 1987; Solomon et al., 1991). It is important to note, 
however, that many of these studies were not capable of utilizing fiber-typing protocols the could 
distinguish all four adult muscle fiber types, especially IIX and IIB, which represent 
approximately 80% of the total fibers in the longissimus muscle of pigs (Larzul et al., 1997). 
Therefore, changes in MHC isoforms could be used to detect alterations in muscle’s functional 
characteristics and carcass muscle composition as a result of growth promoter administration in 
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cattle. Furthermore the same fiber type of MHC may differ in functional characteristics between 
species, and this may explain differences in types of isoforms detected between porcine and 
bovine species. Studies have also measured the relative amount of myosin light chain (MLC) 
isoforms and found that extensive variations exist in isoforms expressed in skeletal muscle 
fibers, yet there are distinct patterns among different species and among muscles within an 
individual specie (Bicer and Reiser, 2004). More recent studies have set out to measure changes 
in MHC fiber type as a result of exogenous growth promoter use to analyze alterations in skeletal 
muscle hypertrophy. These reports will be addressed later in this review. 
Anabolic Steroids 
 Anabolic steroids belong to the steroid super-family and are potent stimulators of skeletal 
muscle growth. Steroidogenic enzymes are responsible for the biosynthesis from cholesterol of 
various steroid hormones including glucocorticoids, mineralcorticoids, progestins, androgens, 
and estrogens (Sanderson, 2006). The adrenal gland is an important steroidogenic tissue in the 
human body, and unlike the gonads, it produces adrenal hormones that are essential for survival 
(Addison, 1855). Steroid hormone ligands are highly hydrophobic in nature which allows them 
to pass through the plasma membrane (Geisler, 2003). The two primary classes of anabolic 
steroids currently used in the cattle finishing industry are androgens and estrogens. Both of these 
steroids have a biological effect in most livestock species as well as in humans. The purpose of 
anabolic steroid use in livestock and specifically cattle is to improve the rate and efficiency of 
gain. Trenbolone is a synthetic androgen that is similar in structure to testosterone (Anderson, 
1991). Trenbolone acetate (TBA) has approximately 50 times the anabolic potency of 
testosterone and is 8-10 times stronger than testosterone propionate (Neumann, 1976). Estradiol-
17β (E2) is an estrogenic hormone that is naturally produced in vivo, and can be synthetically 
produced. The combination of TBA and E2 were approved for use in the United States in 1992, 
and are the most common combination of steroidal implants used currently in finishing cattle.  
Effect of Anabolic Steroid on Growth 
 Cellular responses to steroid hormones are mediated by receptors that initiate a complex 
range of cellular events upon ligand binding. These cellular responses can be classified into the 
two broad groups of genomic or rapid signaling responses. The genomic response is the classical 
response that is characterized by changes in gene transcription and occurs over the time course of 
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hours to days (Prossnitz et al., 2008). With genomic responses, steroid ligands bind to the 
intracellular steroid receptors and effect the regulation of transcription factors and protein 
synthesis (Beato et al., 1996). There are two known estrogen receptors. The first one was 
discovered in 1973 and is termed ERα (Jensen et al., 1973). The second estrogen receptor was 
discovered in 1996 and is termed ERβ (Kuiper et al., 1996). Testosterone action is mediated by 
the androgen receptor, which transduces the steroid signal within cells (Mateescu and Thonney, 
2005). It is thought that TBA may act on skeletal muscle through glucocorticoid receptors to 
reduce the catabolic effect of glucocorticoids (Muir, 1985). It has also been suggested that 
testosterone can up-regulate RNA polymerase and ribosomal activity in rat skeletal muscle 
(Breuer and Florini, 1965; Florini and Breuer, 1966). These studies show that direct effects occur 
by steroids ligand binding to the specific intracellular, steroid receptors and individual steroids 
may be ligands for multiple types of steroid receptors.  
 The other type of cellular response is a rapid signaling response that can occur within a 
matter of seconds to minutes of cell stimulation (Prossnitz et al., 2008). Rapid signaling 
responses are often associated with growth factor receptors and transmembrane G-protein 
coupled receptors (GPCR). Steroid ligands bind to the GPCR on the outer surface of the cell 
membrane. Ligand-activated GPCRs can bind directly to intracellular proteins, resulting in 
receptor and cellular regulation (Bockaert et al., 2004). One study demonstrated how GPR30 (a 
GPCR) was involved in estrogen-mediated activation of ERK1/2 (a mitogen-activated protein 
kinase) in cells lacking classical nuclear estrogen receptors (Filardo et al., 2000). Another study 
by Kamanga-Solla et al. (in press) suggested that the GPR-30 receptor may be involved in E2-
stimulated IGF-I expression in muscle. These GPCR are related to cellular responses such as 
calcium mobilization, kinase activation, and nitric oxide production (Prossnitz et al., 2008). One 
reason this process may be so rapid is that the ligand binding occurs in extracellular space, as 
apposed to the classical intracellular binding with genomic responses. These studies show that 
direct steroid activity is a very complex issue that is capable of mediating growth through 
various courses of action. 
 One component of anabolic steroid’s ability to indirectly stimulate muscle growth is 
through its effect on insulin-like growth factor-I (IGF-I). In studies, IGF-I has been shown to be 
a potent stimulator of protein synthesis in skeletal muscle by its role in satellite cells activity, as 
well as being able to reduce the rate of protein degradation (Florini et al., 1996; Barton-Davis et 
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al., 1999). With implantation of TBA and E2 there was an increase in the levels of IGF-I 
circulating, and longissimus muscles of steers expressed higher levels of IGF-I mRNA when 
compared to non-implanted steers after 30 to 40 days (Frey et al., 1995; Johnson et al., 1996, 
1998a; Dunn et al., 2003; White et al., 2003). It was determined that IGF-I mRNA levels are 
greater in biopsy samples from the longissimus muscle as early as 12 days after being implanted 
with TBA + E2 in steers, when compared to non-implanted steer (Pampusch et al., 2003).  
 Another way that anabolic steroids achieve increases in skeletal muscle accretion is 
though increases in skeletal muscle satellite cells. Steers that received an implant containing the 
combination of TBA and E2 were found to have a greater number of proliferating satellite cells 
isolated from skeletal muscle tissue, 24 and 34 hours post implantation, as well as greater rates of 
proliferation 31 days post implantation (Johnson et al., 1998a). There was also 18% greater 
fusion of satellite cells from cultures of muscle tissue from the implanted steers versus the non-
implanted group. Furthermore, the implanted group had 38% more nuclei found in the myotubes 
of the fused cultures compared to the non-implanted group (Johnson et al., 1998a). In another 
study, in vitro methods were used to analyze the direct effect of TBA and E2 on proliferation of 
satellite cell cultures that were obtained from non-implanted steers (Kamanga-Sollo et al., 2004). 
These results found that exposing the satellite cells to 10 nM estradiol or 10 nM trenbolone 
resulted in rates of proliferation 1.5 times greater than the rate of the control group. One factor 
that is important to recognize is that in order to overcome the antagonistic action of IGFBP-3 on 
IGF-I, the media used in the culture was depleted of IGFBP-3 (Kamanga-Sollo et al., 2004). 
These studies show that anabolic steroids affect growth through various pathways, many of 
which lead to dramatic effects on the performance of meat producing animals. Furthermore, the 
accumulation of DNA from satellite cells into muscle fibers is an important aspect of postnatal 
skeletal muscle growth, which can be altered by the use of anabolic steroids. 
Effect of Anabolic Steroids on Performance 
 Anabolic steroids enhance muscle growth, improve rate of gain, and increase feed 
efficiency in cattle (Johnson et al., 1996; Pampusch et al., 2003). Heifers administered estrogen 
only compounds were found to have increases in daily gains by 12 to 16% (Dinnusson et al., 
1950). Steers implanted with the combination of TBA and E2 were found to have improvements 
in ADG, feed efficiency, longissimus muscle area, and carcass protein, with no effects on DMI 
or fat accumulation (Johnson et al., 1996; Pampusch et al., 2003). In a study comparing TBA 
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only, E2 only, and TBA/E2 combined, in yearling steers, average daily gain and skeletal muscle 
protein content were greatest in the group receiving the combination of TBA/E2, followed by E2 
only, and the weakest response was in TBA only group (Hayden et al., 1992). The combination 
of TBA/E2 has also been found to increase rib protein percent and decrease rib fat percent in 
implanted steers (Lee et al., 1990). Another study by Platter et al. (2003) analyzed the impact of 
lifetime implant protocols on performance and quality of beef steers. They found that with more 
repetitive and aggressiveness of implant protocols, there were increases in live and carcass 
performance; however marbling, tenderness, and consumer acceptability were decreased (Platter 
et al., 2003). The impact that steroids have on skeletal muscle accretion is well established and 
accepted, however the methods and mechanisms that elicit the response in vivo is still not fully 
understood. 
β-Adrenergic Agonists 
 Compounds known as β-AA are capable of eliciting a biological response when bound to 
a β-AR (Mersmann, 1998). These β-AA belong to the class of compounds known as 
phenethanolamines (Barnes, 1995), and are either endogenous structures that are naturally 
synthesized within the body, or exogenous compounds that are synthetically produced outside 
the body. Two endogenous phenethanolamines are the catecholamines, epinephrine and 
norepinephrine (Smith, 1998). Both of these compounds vary in their affinity to the β-AR as well 
as the response they elicit through the receptors. Exogenous compounds are orally administered 
to elicit a biological response in livestock species. There are two types of β-AA that are utilized 
to improve growth efficiency and productivity in finishing beef cattle and in swine. 
Ractopamine-HCl (RH) was approved by the FDA for use in pigs in 1999 as well as in cattle in 
2003. The β1-AA RH, marketed as PayleanTM, can be orally administered to pigs in the feed up 
to 10 mg/kg of diet during the last 20.4 to 40.8 kg of weight gain. RH is also marketed as 
OptaflexxTM, and it can be fed up to 400 mg per head daily to feedlot cattle for the last 28 to 42 
days prior to harvest with no withdrawal period. The other type of β-AA that was approved in the 
United States in 2006 for use in cattle was the β2-AA Zilpaterol-HCl (ZH), marketed as 
ZilmaxTM. It can be fed from 60 to 90 mg per head daily to for the last 20 to 40 days prior to 
harvest, with a three day withdrawal period. Zilmax is only approved for use in feedlot cattle. 
There are several other β-AA such as cimaterol, clenbuterol, isoproterenol, L-644,969, and 
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salbutamol, that are not currently approved for use with finishing cattle in the United States 
(Moody et al., 2000; Mersmann et al., 1998; Smith, 1998). Each of these β-AA has varying 
physiological responses in growth rate and lean tissue accretion due to differences in 
conformational structure.  
β-Adrenergic Agonist Receptors 
 The primary way for β-AAs to directly produce a biological response is to bind to β-
adrenergic receptors (β-AR) on the cell surface. Almost all cell types within the mammalian 
body have β-AR integrated into the plasma membrane (Mersmann, 1998). There are three types 
of β-AR that have been discovered, and they are referred to as β1-, β2-, and β3-AR. There is 
approximately 40 to 50% homology between receptor subtypes within a species (Mersmann, 
1998). When compared across species there is 75% or greater homology for any of the β-AR 
subtype (Pietri-Rouxel and Strosberg, 1995). Therefore the number and type of receptors can 
vary within and between species. The primary receptor found in bovine adipose tissue is the β2 
receptor (Van Liefde et al., 1994). Other studies have determined that the β2-AR is the most 
abundant subtype in both the longissimus dorsi muscle as well as in peri-renal adipose tissue of 
cattle (Sillence and Matthews, 1994). Furthermore, recent studies on semimembranosus muscle 
of steers and heifers have shown that the most abundant β-AR mRNA detected was for the β2-
AR subtype (Winterholler et al., 2006; Sissom et al., 2007a). The β2-AA ZH can bind to both the 
β1-AR and β2-AR, although it has a greater affinity for the β2-AR (Verhoeckx et al., 2005). 
Across all the types of β-ARs, there exist similar physical characteristics. 
 The β-AR is comprised of >400 amino acids in a continuous chain that are anchored to 
the plasma membrane by seven relatively hydrophobic transmembrane domains (Mersmann, 
1998). Unlike anabolic steroids, βAA can not pass through the cell membrane, and therefore 
ligand binding occurs on the extracellular portion of the cell, which activates the intracellular 
portion of the β-AR/GS or β-AR/GI complex. The activation of the GS complex leads to 
activation of adenylyl cyclase to produce cyclic AMP from ATP. Increases in cAMP activate 
protein kinase A, which leads to the phosphorylation of the serine/threonine residues of key 
protein enzymes. This can either cause activation or inactivation of these protein enzymes. One 
such protein that can be activated is hormone sensitive lipase that is the rate limiting step in 
lypolysis (Mersmann, 1998). A protein that can be inactivated is acetyl CoA carboxylase which 
is the rate limiting step in lipogenesis (Liggett and Raymond, 1993). Gene activation can also be 
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affected by protein kinase A (PKA) phosphorylating transcription factors like cAMP response 
element binding protein (CREB), which binds to DNA (Mersmann, 1998). Other studies have 
reported on β-AA effect of increasing in the amount of RNA transcript for the muscle proteins 
myosin light chain (Smith et al. 1989), α-actin (Helferich et al. 1990; Grant et al. 1993), and 
calpastain (Bardsley et al. 1992). These biological responses from the activation of β-AR 
indicate how tissue deposition and accumulation can be directly affected. 
 The administration of β-AA appears to increase efficiency of growth by preferentially 
stimulating skeletal muscle growth compared to adipose tissue. It is thought that β-AA achieve 
this through decreasing the natural in vivo degradation of protein, and increasing protein 
translated from RNA. Data suggests that β-AA may contribute to lean muscle mass by acting 
upon the calpain-calpastatin complex and decreasing protein degradation (Pringle et al., 1993). 
Steers receiving close arterial infusion of cimaterol had increased calpastatin mRNA (Sun et al., 
1994). Myoblast from rats were exposed to cimaterol and there was a decrease in protein 
degradation, but no effect on protein synthesis (Forsberg and Merrill, 1986). Pigs that were 
administered ractopamine had an increase in fractional protein synthesis rates and a decrease in 
fractional protein breakdown rate (Bergen et al., 1989). In a study with steers that were 
administered clenbuterol, mRNA transcripts of specific muscle proteins increased by 90% in the 
longissimus muscle (Smith et al., 1995). Another study administered L-644,969 to steers and 
noticed a 27% reduction in the fractional degradation rate of protein (Wheeler and Koohmaraie, 
1992). Ractopamine was found to decrease adipose tissue sensitivity to insulin in rats (Hausman 
et al., 1989) and in pigs (Liu and Mills, 1990). It has also been observed that chronic treatment of 
β-AA increases sensitivity to insulin in the soleus muscle of rats (Budohoski et al., 1987). These 
studies show how β-AA may alter glucose uptake by adipose tissue, and repartition those 
nutrients to other tissues like muscle, as well as reducing rate of protein turnover, and ultimately 
increasing total protein accumulation.  
 It has also been hypothesized that β-AA may have an indirect effect on hypertrophy 
though increased blood flow. Steers that were administered cimaterol through close arterial 
infusion increased the rate of blood flow and extraction of essential amino acids from the 
circulation in the hind limb where it was administered (Byrem et al., 1996). Similar results were 
reported in cattle administered clenbuterol (Eisemann and Huntington, 1993) and in lambs 
administered clenbuterol (Aurousseau et al., 1993). These studies show that β-AA do have 
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indirect tissue altering ability by increasing blood flow which could result in more nutrients and 
factors being made available to specific tissues. Another possible indirect effect that has been 
studied is β-AA effect on satellite cell activity. 
 There has been little evidence to show that β-AA have any effect on satellite cell activity. 
In a study conducted on rats, DNA synthesis was inhibited in the soleus muscle, but there were 
no significant alterations in the extent of muscle hypertrophy or myofibril content (Fleckman et 
al., 1978). When lambs were administered cimaterol, the semitendinosus muscle had greater 
levels of protein and RNA content, and a decrease in DNA concentrations after 7 weeks of 
administration, which then returned to normal after 12 weeks of administration (Beermann et al., 
1987). In a similar study, Kim et al. (1987) had the same conclusion. When O’Conner et al. 
(1991) conducted a study with sheep administered cimaterol for 3 weeks they noticed a 25% 
increase in RNA concentrations, 85% increase in total mass of RNA, and a 30% increase in total 
weight gain. At the same time there was a 42% reduction in DNA concentration, and the total 
DNA content was unchanged (O’Connor et al., 1991). Sissom et al. (2007b) cultured bovine 
satellite cells in vitro in media containing ZH, and no changes were detected in satellite cell 
proliferation. In an in vivo study with cull beef cows administered RH, there were no changes in 
satellite cell numbers or fiber-associated nuclei (Gonzalez et al., 2007). These studies suggest 
that stimulation of satellite cell activity was not an essential aspect of this muscle hypertrophy. 
Furthermore, β-AA did not affect satellite cell proliferation or incorporation into the growing 
muscle fibers. Therefore it is possible that β-AA can stimulate muscle hypertrophy, and elicit a 
response without stimulating satellite cell activity. This phenomenon brings to light the possible 
additive effects of β-AA administered in combination with anabolic steroids, which, as discussed 
earlier, have been found to stimulate satellite cells. An important factor contributing to possible 
additive effects is the ability of β-AA to affect protein synthesis and degradation. An indicator of 
this biological activity can be measured through the gene expression of the muscle specific 
protein being synthesized. As discussed earlier, one of the major proteins involved in protein 
synthesis is myosin, and more specifically MHC.  
 Feeding cimaterol to lambs reduces type I MHC fibers, and muscle hypertrophy is 
primarily attributed to type II fibers (Beerman et al., 1987). Clenbuterol was administered to rats 
and type II fibers were found to increase, whereas type I fibers decreased in the soleus muscle 
(Zeman et al., 1988). In a similar study with rats administered clenbuterol, there was a decrease 
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in the type I MHC and a high amount of type IIX MHC present, which was not detected in the 
control group. There was also a decrease in the types I, IIA, and IIX in the diaphragm muscle, 
but an increase in type IIB (Polla, et al., 2001).  Another study evaluated the effects of 
ractopamine in pigs and found that types IIA and IIX decreased, however type IIB was found to 
increase (Depreux et al., 2002; Gunawan et al., 2007). These studies imply that β-AA feeding 
stimulates fibers to transition from slow to faster phenotypes, and faster fiber types of MHC are 
larger in diameter than slower fiber types (Taylor, 2004). This is could explain the increase in 
total muscle size that has been observed with administration of β-AA. 
Effect of β-Adrenergic Agonist on Performance 
 Different species of animals appear to have different responsiveness to β-AA (Anderson 
et al., 1991). Ruminants, sheep and cattle, have a greater response to β-AA compared to swine, 
and poultry appear to be the least responsive livestock specie (Moody et al., 2000). The low 
responsiveness in chickens has been attributed to the high genetic selection for growth potential 
in broilers, which show they may be approaching their biological maximum growth rate 
(Mersmann, 1998). This could explain greater responses observed in cattle and sheep that have 
not been so rigorously selected for growth potential. 
 Feeding of β-AA enhances carcass leanness, improves growth rates, and decreases feed 
consumption in cattle and sheep (Plascencia et al., 1999; Salinas-Chavira et al., 2004). Most 
studies evaluating β-AA have also implanted cattle with an anabolic steroid. This is to reflect the 
regimen of growth promoters that are typically used in the conventional beef finishing industry. 
Steers implanted with Revalor-S and administered RH were found to have increased ADG, G:F, 
HCW, and LM area, with no changes in feed intake, dressing percentage, USDA yield grade, or 
quality grade (Winterholler et al., 2007). A similar study that evaluated the performance of 
heifers implanted with Finaplix-H and administered RH, found an increase in ADG, G:F, HCW, 
and LM; improved yield grade; and decreased 12th rib fat depth (Sissom et al., 2007a). The β2-
AA ZH is expected to have similar, if not greater, effect on performance relative to RH due to 
type of β-AA and affinity to the β2-AR which is the most abundant in skeletal muscle. Steers 
implanted with Revalor-S and administered ZH were found to have an increase in ADG, G:F, 
HCW, dressing percentage, and LM area. There was also a decrease in feed intake, 12th rib fat 
depth, marbling, KPH and yield grade (Vasconcelos et al, 2008). Another study showed that 
steers implanted with Synovex Plus and administered ZH had greater ADG, HCW, G:F, and 
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carcass yield, but no effect on feed intake (Avendaño-Reyes et al., 2006). In another study, steers 
that were implanted with Revalor and administered ZH were found to have similar performance, 
but with no differences in feed intake, 12th rib fat depth, or marbling (Plascentia et al., 1999). It 
is important to note that each of these studies used different breeds as well as variations in 
physiological endpoints that these animals were harvested at. Because almost all studies 
evaluating ZH in finishing cattle have preceded ZH administration with a steroid implant, it is 
difficult to accurately determine what the performance response to the β2-AA would be in non-
implanted cattle. Therefore further studies are needed to determine the extent of performance that 
can be attributed to ZH. 
Anabolic Steroid Use Combined with a β-Adrenergic Agonist 
 Little research has looked into the combined effects of anabolic steroids and β-AA on the 
performance and carcass characteristic in cattle. Studies have compared the effects of steroid 
hormones and bovine growth hormone on performance and carcass characteristics in cattle. 
These studies reported that steroid hormones and growth hormone have additive improvements 
on performance in cattle (Enright et al., 1990; Preston et al., 1995). Differences in the 
mechanisms of action stimulating skeletal muscle accretion with β-AA and steroid hormones 
have made us question the extent of additive effects on growth, from combined treatment. 
Animal performance is improved by the direct effects of anabolic steroids binding with 
intracellular receptors and eliciting a response through regulation of transcription for tissue 
synthesis and degradation. They also have an indirect effect by stimulating satellite cell 
proliferation which increases the overall capacity for hypertrophic growth. Administration of β-
AA directly affects the extent that DNA transcribes RNA and in turn translates protein. Due to 
this, it has been hypothesized that anabolic steroids elicit biological responses that synthesize the 
“machinery” that is necessary for hypertrophy, and β-AA improve the efficiency with which that 
“machinery” is capable of accumulation of protein through hypertrophy. Therefore, the increased 
growth response could be synergistic, if not additive, in nature with the combination of these two 
growth promoters in finishing beef cattle. 
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Conclusion 
 As the world population continues to grow, the demand on agriculture to produce 
sufficient food is becoming more pronounced. Our dependence on photosynthesis to provide the 
world with food, fabric, and fuel has driven science to evolve the most efficient practices to 
utilize every aspect of this process. One practice the beef cattle industry in the United States has 
adopted is the use of exogenous growth promoting agents to increase the efficiency that nutrients 
are converted to edible protein. Examples of this are seen in the improved performance of 
finishing beef cattle that are administered anabolic steroids and β-adrenergic agonist. The 
biological processes that enable these changes in animal growth are complex and intriguing; 
however, science has worked to provide a better understanding by investing in research to focus 
on this issue. With demands for red meat products increasing and the natural resources available 
for its production decreasing, it is important that we consider, and utilize practices that will 
efficiently and safely provide the world with wholesome red meat beef products. 
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Abstract 
This experiment investigated the effects of zilpaterol-HCl (ZH) and the steroidal implant 
Revalor-S (RS; 120 mg trenbolone acetate and 24 mg estradiol-17β) on finishing steer 
performance and the mRNA concentration of β-adrenergic receptors (β-AR) types I and II, 
calpastatin, and types I, IIA, and IIX myosin heavy chain (MHC) isoforms. A total of 2,279 
feedlot steers weighing 426 ± 6.4 kg were administered no implant or RS on d 0, and fed either 0 
or 8.3 mg ZH/kg of diet DM during the last 30 d with a 3 d withdrawal. Treatments were 
randomly assigned to 24 pens (n = 6 pens/treatment). At harvest, semimembranosus muscle 
tissue was excised for RNA isolation from 4 carcasses per pen. No interactions were detected for 
any of the variables measured in the experiment. Administration of ZH during the last 30 d of the 
feeding period increased (P < 0.01) ADG, G:F, HCW, and LM area; decreased (P < 0.01) 12th 
rib fat depth and marbling; and improved (P < 0.01) yield grade. Treatment had no effect on β1-
AR mRNA levels, but there was an increase (P = 0.01) in β2-AR mRNA levels due to ZH 
inclusion. Myosin heavy chain-I (MHC-I) mRNA levels were unaffected by treatment. For 
MHC-IIA mRNA concentrations, administration of RS tended (P = 0.08) to increase mRNA 
levels, whereas ZH feeding the last 30 d tended (P = 0.08) to decrease mRNA levels for this 
isoform of myosin. Feeding ZH the last 30 d prior to harvest, increased (P < 0.01) mRNA 
concentrations of MHC-IIX in semimembranosus muscle of steers. These data indicate the 
combined use of ZH and RS additively contributes to live and carcass gain in finishing feedlot 
steers. In addition, ZH feeding changes the mRNA levels of MHC isoforms to a faster, more 
glycolytic fiber type in bovine skeletal muscle. These changes in mRNA concentrations of MHC 
isoforms due to ZH feeding could be affecting skeletal muscle hypertrophy. 
 
 31
Introduction 
 Zilpaterol-HCl (ZH) is an orally active β-adrenergic agonist (β-AA) approved for use in 
finishing beef cattle in the United States. Inclusion of ZH in cattle feed the last 20 to 40 d, 
improves ADG, feed efficiency, carcass yield grade, HCW, LM area and dressing percentage in 
finishing steers (Avendaño-Reyes et al., 2006; Vasconcelos et al., 2008). These biological effects 
are a result of ZH binding to a β-adrenergic receptor (β-AR) located on the cell surface of tissues 
including skeletal muscle and adipose tissue (Mersmann, 1998). There are 3 sub-types of β-AR 
(β1, β2, and β3) on most mammalian cells with β2-AR being the most abundant receptor sub-
type in bovine skeletal muscle and adipose tissue (Sillence and Matthews, 1994). Zilpaterol-HCl 
can bind to both the β1-AR and β2-AR, with a greater affinity for β2-AR (Verhoeckx et al., 
2005). The β-AA increase skeletal muscle hypertrophy. These improvements in skeletal muscle 
hypertrophy are a result of changes in protein synthesis and degradation rates, whereas in 
adipose tissue they promote lipolysis (Beermann, 2002; Birkelo, 2003; Verhoeckx et al., 2005). 
 Anabolic steroidal implants containing the combination of trenbolone acetate (TBA) and 
estradiol-17β (E2) have been reported to improve feedlot performance and stimulate carcass 
protein accretion in feedlot steers (Johnson et al., 1996; Pampusch et al., 2003). Data also 
indicates that TBA + E2 implantation increases proliferation, and fusion of muscle satellite cells, 
which may be an important mechanism by which anabolic steroids enhance muscle hypertrophy 
(Johnson et al., 1998; Johnson and Chung, 2007). 
 Currently, there are no data on the comparative efficacy of these 2 distinct types of 
growth promotants in the feedlot steers in the United States. The purpose of this study was to 
investigate the effects of ZH administration in combination with a steroidal implant containing 
TBA and E2 on steer performance and the mRNA abundance for β1-AR; β2-AR; calpastatin; 
and myosin heavy chain (MHC) types -I, -IIA, and -IIX.  
Material and Methods 
 The following experiments were a collaboration of Intervet Inc. (Millsboro, DE), Texas 
Tech University, and Kansas State University. Experimental procedures with cattle were in 
compliance with the guidelines stated in the Guide for the Care and Use of Agricultural Animals 
in Agricultural Research and Teaching (FASS 1999). 
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Animals  
English X Continental yearling steers (n = 2,279), with initial BW of 426 ± 6.4 kg, were 
utilized in this study. All animals were housed at a commercial research facility in Texas in soil-
surface pens. At approximately d -61, all animals were administered a Component TE-IS (16 mg 
estradiol and 80 mg TBA; Vetlife Inc., West Des Moines, IA) implant. Prior to allotment, 
animals were weighed and ultrasound was used to estimate empty body fat (EBF), so that pens 
could be stratified by EBF. Extreme animals in terms of BW or EBF were removed from the 
trial. Furthermore, animals with missing EID tags or with visual performance or health problems 
were also eliminated from the trial. 
Experimental Design, Treatment, and Pen Assignment 
Four treatments were arranged in a 2 x 2 factorial design with the main effects of feeding 
ZH (0 or 8.38 mg/kg; Zilmax; Intervet, Inc., Millsboro, DE) for the last 30 d on feed with a 3 d 
withdrawal (in accordance with FDA regulations), and a terminal implant of Revalor-S (RS; 120 
mg TBA and 24 mg E2; Intervet, Inc., Millsboro, DE) 91 d before harvest or no implant. 
Treatments were randomly assigned to each pen (n = 24) with approximately 100 steers per pen, 
as follows: 1) no RS or ZH (CON) or 2) only ZH [ZH], 3) only RS (RS) or 4) RS and ZH 
[ZH+RS]. The different treatment groups were designed to be reflective of the typical 
commercial finishing period, and to evaluate the impact of inclusion of ZH in the diet. The ZH 
was included by means of a ground corn-based premix (Table 2.1). When the study was 
conducted ZH was not approved by the FDA to be fed in combination with monensin 
(Rumensin; Elanco Animal Health, Indianapolis, IN) or tylosin (Tylan; Elanco Animal Health, 
Indianapolis, IN); therefore, during the ZH feeding period, these feed additives were removed 
from the diets of the treatments receiving ZH for 30 d, then administered again during the 3 d 
withdrawal to all treatments. The diet ingredient and chemical compositions are provided in 
Table 2.1. The diet was formulated to meet or exceed NRC (1996) requirements for nutrients. 
Throughout this study a clean bunk method was implemented so that all feed was consumed each 
day without limiting feed available. Feed allocation (increase or decrease in daily amount) was 
based on the time bunks were empty and visual appraisal of cattle appetite aggression. Cattle 
were fed 3 times daily with approximately equal distribution of the day’s feed across the 3 
feedings. Pens were fed in the same order each day. At the end of the feeding period BW was 
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measured, and the industry standard, 4% pencil shrink, was used to calculate final BW. All 
animals were transported approximately 193 km to a commercial abattoir to be harvested. 
Sample Preparation and RNA Isolation 
Within 10 min of slaughter at the abattoir, a muscle sample was collected from the 
semimembranosus muscle of 4 randomly selected steers per pen. The samples were rapidly 
frozen in liquid N2 and shipped to Kansas State University for analysis. Total RNA was isolated 
from muscle samples with Tri Reagent (Sigma, St. Louis, MO). Briefly, the semimembranosus 
muscle tissue (200 mg) was transferred to a steel mortar bowl cooled by liquid N2. The samples 
were homogenized by using a sterile pestal in liquid N2, and Tri Reagent (2 mL) was added to 
the ground tissue sample. Muscle tissue (1 mL) in Tri Reagent was incubated at room 
temperature for 5 min. After incubation, chloroform (Sigma, St. Louis, MO) was added, and the 
samples were centrifuged for 15 min at 12,000 x g at room temperature. After centrifugation, the 
upper aqueous phase was removed and transferred to a new microcentrifuge tube. Isopropanol 
(Sigma, St. Louis, MO) was added, and incubated at room temperature for 5 min. Then the 
samples were centrifuged for 10 min at 12,000 x g to isolate the RNA pellet. The isopropanol 
was then removed and the RNA pellet was suspended in 70% ethyl alcohol (1 mL) and stored at 
-80ºC. 
 The RNA pellet was treated to remove any contaminating genomic DNA by using the 
DNA-free kit (Ambion, Austin, TX). The RNA concentration was determined by absorbance at 
260nm. The integrity of the RNA was determined by gel electrophoresis. Total RNA with 
ethidium bromide was loaded onto a 1% agarose gel to separate and visualize the 28S and 18S 
ribosomal RNA (18S). Total RNA (1 μg) was then reverse-transcribed to produce the first-strand 
complementary DNA (cDNA) using TaqMan Reverse Transcription Reagents and Multi-Scribe 
Reverse Transcriptase (Applied Biosystems, Foster City, CA) following the protocol 
recommended by the manufacturer. Random hexamers were used as primers in cDNA synthesis. 
Real-Time Quantitative PCR 
Real-time quantitative PCR was used to measure β1-AR, β2-AR, calpastatin, MHC-I, 
MHC-IIA, and MHC-IIB quantitative gene expression relative to the quantity of ribosomal 
protein S9 (RPS9) in total RNA isolated from muscle tissue. Measurements of the relative 
quantity of cDNA was performed by using TaqMan Universal PCR Master Mix (Applied 
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Biosystems, Foster City, CA), 900 nM of the appropriate forward and reverse primers, 200 nM 
of the appropriate TaqMan detection probe, and 1 μL of the cDNA mixture. The bovine-specific 
β1-AR, β2-AR, calpastatin, MHC-I, MHC-IIA, and MHC-IIB forward and reverse primers and 
TaqMan detection probes (Table 2.2) were synthesized by using published GenBank sequences. 
Custom RPS9 (Genbank Accession No. DT860044) rRNA primers and probes were used as an 
endogenous control. The ABI Prism 7000 detection system (Applied Biosystems, Foster City, 
CA) was used to perform the assay by using the recommended thermal cycling variables from 
the manufacturer (50 cycles of 15 s at 95˚C and 1 min at 60˚C). The RPS9 rRNA endogenous 
control was used to normalize the expression of β1-AR, β2-AR, calpastatin, MHC-I, MHC-IIA, 
and MHC-IIB. The data were expressed as relative units. 
 Statistical Analysis 
Data were analyzed as a 2 x 2 factorial in a randomized complete block design with 
PROC MIXED (SAS Inst. Inc., Cary, NC). Pen served as experimental unit for all feedlot, 
carcass characteristics, and gene expression data. Treatment and interaction means were 
analyzed and separated (P < 0.05) with the least significant difference procedure of SAS and 
Fisher’s exact test. 
Results and Discussion 
Effect of ZH and RS on Performance and Carcass Characteristics 
Performance data represent the entire 91-d period from RS implant until harvest. All 
performance and carcass data are shown in Table 2.3. The RS treatment increased (P < 0.01) 
ADG and G:F, and increased (P = 0.02) DMI by 2.2%. These results are similar to previous 
studies on steroidal implants showing improvements on finishing steer performance and feed 
efficiency (Bartle et al., 1992; Johnson et al., 1996; Guiroy et al., 2002; Pampusch et al., 2003). 
The increase in DMI was in agreement with previous studies utilizing estrogen implants that 
reported an increase in DMI (Rumsey et al., 1992).  
 Carcass yield improved with increases (P < 0.01) in HCW and LM area as well as an 
increase (P < 0.05) in dressing percentage as a result of RS treatment (Table 2.3). There was a 
change in quality grade, with marbling scores decreasing (P < 0.01) with RS treatment; however, 
no differences were observed for 12th rib fat depth. Our results are similar to a previous study 
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that found improvements in performance with implant use; however quality grade also decreased 
with increased implant use in steers (Platter et al., 2003). These results show that RS implant 
improves finishing steer performance through increased efficiency of nutrient conversion to 
skeletal protein; however it does have a negative impact on carcass quality grade due to 
decreases in final adipose amounts. 
 The ZH treatment increased (P < 0.01) ADG, G:F, HCW, dressing percentage, and LM 
area; and decreased (P < 0.01) 12th rib fat depth and marbling scores. With the ZH treatment, 
there was no effect on DMI. These results show that ZH improves performance, and enhances 
carcass protein accumulation without stimulating DMI, leading to improved efficiency with 
which dietary nutrients are converted to gain. However, there is a reduction in adipose tissue. 
These results are similar to other studies that have detected increases in performance and carcass 
lean tissue accumulation in cattle and sheep (Plascencia et al., 1999; Salinas-Chavira et al., 
2004). 
 It is known that the response of ZH in cattle is mediated through the β-AA binding and 
activation of β-AR. Zilpaterol hydrochloride functions mainly though the β2-AR which 
predominates in skeletal muscle and adipocytes in cattle (Birkelo, 2003). Once the receptors are 
activated, intracellular actions are mediated through cyclic AMP and subsequent activation or 
deactivation of key enzymes. The net effect is to direct nutrients in support of enhanced protein 
synthesis (Birkelo, 2003). It has been demonstrated that β-AA promote triacylglycerol 
degradation in the adipocyte and block fatty acid synthesis in vitro (Mersmann, 1998). Research 
conducted in vivo with heifers showed that clenbuterol administration reduced adipocyte cell 
volume, suggesting the depression in lipid deposition was due to the inhibition of pivotal 
enzymes necessary for de novo fatty acid biosynthesis (Smith et al., 1987). Our understanding of 
the primary method with which ZH elicits a biological response supports the results observed in 
the current study, as well as the concept that ZH acts as a repartitioning agent to disrupt the 
ability of adipose tissue to utilize nutrients, making more nutrients available for muscle 
hypertrophy. 
 The cattle receiving the combination ZH+RS treatment had the greatest increase in ADG 
and G:F that appear to be additive when compared to the individual treatments with ZH or RS. 
The ZH+RS treatment also had an additive increase in HCW, LM and dressing percentage when 
compared to individual treatments of ZH or RS. Marbling scores, 12th rib fat depth, and KPH 
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were additively decreased for the ZH+RS treatment when compared to individual treatments of 
ZH or RS. There is little published research available that compares the effects of implants and 
ZH in cattle, however, these results are supported by similar studies that found increases in 
ADG, G:F, HCW, dressing percentage, and LM area; decreases yield grade, 12th rib fat depth, 
and marbling scores in finishing steers that were administered RS (120 mg TBA and 24 mg E2) 
and received feed inclusion of ZH (8.33 mg/kg) for 0, 20, 30, or 40 d (Vasconcelos et al., 2008). 
Similarly, Avendaño-Reyes et al. (2006) reported increased ADG, G:F, HCW, and LM area; 
decreased 12th-rib fat depth and no difference in DMI by steers that received Synovex Plus (200 
mg TBA and 28 mg estradiol benzoate) 60 d before ZH administration (Avendaño-Reyes et al., 
2006).  
 These results support our findings that steroid implant and inclusion of ZH in typical 
finishing steer rations, improve feed efficiency and animal performance without affecting DMI. 
Furthermore, the largest improvements in performance and efficiency are achieved, and appear 
to be completely additive, when steers are administered a steroidal implant prior to inclusion of 
ZH in the ration; however carcass quality decreases to a similar extent. The additive nature of the 
data implies that these 2 growth promotants may be working through distinct mechanisms to 
enhance lean tissue deposition. 
Real Time PCR 
In performing the real time PCR, we initially determined quantitative values of each gene 
of interest relative to the quantity of the housekeeping gene (HKG) 18S rRNA to normalize the 
data. From our analysis, we determined there was a treatment effect (P = 0.05) of ZH on 18S 
rRNA concentrations. Total RNA isolated from muscle samples of ZH cattle had greater levels 
of 18S rRNA. Therefore, we used RPS9 as our HKG. In a previous study, various HKG were 
tested for variation with bovine hepatic tissue from animals of varying physiological and dietary 
experimental conditions. It was determined that of those tested the HKG RPS9 was the most 
stable relative to the various experimental types of hepatic tissue (Janovick-Guretzky et al., 
2007). Following analysis of our study it was determined that no effect (P = 0.43) was detected 
with the HKG RPS9 for any of the treatment groups. From this discovery, the question arises 
about ZH possibly having an effect on ribosomal RNA gene expression. This would be another 
indicator that protein synthesis may be altered with ZH administration. 
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Effect of ZH and RS on Semimembranosus Muscle β1-AR, β2-AR, and Calpastatin mRNA 
Concentrations 
The mRNA concentrations of β-AR and calpastatin are shown in Figures 2.1 through 2.3. 
There was no effect from any treatments on the expression of β1-AR mRNA. The ZH treatment 
increased (P = 0.01) mRNA expression of the β2-AR, however there was no other treatment 
effects on the β2-AR. No significant treatment effects were observed for calpastatin mRNA 
concentrations. These findings are similar to a study by Sissom et al. (2007) in heifers initially 
implanted with 80 mg TBA and 8 mg E2, and re-implanted with 200 mg TBA 96 d prior to 
feeding the β-AA, ractopamine-HCl (RH), for 28 d. These authors reported no change in β1-AR 
mRNA levels, and a tendency to increase β2-AR mRNA levels, due to β-AA administration 
(Sissom et al., 2007). In a similar study by Winterholler et al. (2007), with steers implanted with 
RS and administered RH, there was no β-AA treatment effect on the expression of β1-AR 
mRNA levels. However there was a tendency to increase β2-AR mRNA levels (Winterholler et 
al., 2007). They further determined in vitro that primary bovine muscle cultures, in response to 
RH, showed an increase (P < 0.001) in the β2-AR mRNA level during differentiation, but no 
effect on β1-AR mRNA levels (Winterholler et al., 2007). These studies support our current 
findings that administration of a β-AA in steers can alter expression of skeletal muscle β2-AR 
mRNA. The differences in the amount of change between theses studies could be due to the 
differences in the type and duration of β-AA administered. Additionally, our study determined 
the expression of β2-AR was nearly 1000 times greater than the expression of β1-AR, which 
suggests that the β2-AR is the most abundant β-AR sub-type in the semimembranosus muscle of 
steers. This corresponds with previous research that determined the β2-AR mRNA is the most 
abundant mRNA sub-type in semimembranosus of heifers and steers (Sissom et al., 2007; 
Winterholler et al., 2007) as well as β2-AR being the most abundant receptor in bovine LM and 
peri-renal adipose tissue (Sillence and Matthews, 1994). 
Effect of ZH and RS on Semimembranosus Muscle Type-I, -IIA, and -IIX MHC mRNA 
Concentrations 
Administration of ZH and RS increases lean tissue deposition. From these findings we 
hypothesized that the expression of myosin isoforms had the potential to be altered as a result of 
the changes in lean tissue deposition, due to ZH and RS administration. The gene expression 
results for MHC are shown in Figures 2.4 through 2.6. There was no effect on the expression of 
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MHC-I mRNA for all treatments. The ZH treatment had a tendency to decrease (P = 0.08) MHC-
IIA mRNA, and the RS treatment had a tendency to increase (P = 0.08) the expression of MHC-
IIA mRNA. There was an increase (P < 0.01) in the expression of MHC-IIX mRNA as a result of 
the ZH treatment, but the RS treatment had no effect. Previous studies have shown a decrease in 
abundance of slower fiber types IIA and IIX MHC protein, and an increase in abundance of the 
fiber type IIB MHC in porcine longissimus and semitendinosus muscles, due to β-AA 
administration, (Dupreux et al., 2002). Within the bovine specie one study attempted to detect 
the fiber type IIB MHC mRNA, which is the fastest, most glycolytic fiber type, but none was 
detected in bovine skeletal muscle (Chikuni et al., 2004). This implied that the type IIX MHC 
mRNA is the fastest, most glycolytic myosin fiber type of mRNA expressed in cattle. For this 
reason we did not run an analysis on the expression of type IIB MHC mRNA. In another study 
rats were administered clenbuterol, and soleus muscle fiber types of MHC showed a transition 
from a slower, anaerobic to faster, aerobic fiber types (Polla et al., 2001; Zeman et al., 1988). 
One study showed the transition in muscle fiber types as it relates to increasing physiological 
maturity in cattle. Solomon et al. (1986) used bulls to show that increasing physiological 
maturity increased slow-twitch-oxidative (SO) fiber followed by a plateau, decreased fast-twitch-
oxidative-glycolytic (FOG) fibers, and increased fast-twitch-glycolytic (FG) fibers. Another 
study by Lefaucheur et al. (2004) analyzed difference in myosin isoforms and muscle fiber types 
in pig breeds that differ dramatically in muscle growth by hypertrophy. This study found 
Meishan pigs, which have lower hypertrophy characteristics, had a greater abundance of MHC-I 
isoforms and SO fibers and a lower abundance of MHC type -IIA, -IIX, and -IIB isoforms and 
fewer FOG and FG fiber types when compared to the Large White pigs, which exhibit high 
muscle hypertophy characteristics (Lefaucheur et al., 2004). In another study cull cows were 
utilized to measure the effects of TBA and RH on type -I and -II LM fibers (Gonzalez et al., 
2007). They found that TBA and RH increased the cross sectional area (CSA) and fiber diameter 
of type I fibers with the greatest increase measured in the TBA + RH treatment; however there 
was no effect on the type II fibers. The lack of effect on the type II fibers could be attributed to 
not separating the different isoforms of the type II fibers, as well as the effect of the level of 
physiological maturity on the capacity for muscle hypertrophy (Gonzalez et al., 2007). Another 
study was conducted to analyze the effects of RH on skeletal muscle gene expression in pigs 
(Gunawan et al., 2007). They found that RH differentially induced expression of the type IIB 
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MHC gene (the fastest, most glyoclytic isoform in swine skeletal muscle) at the expense of the 
other isoforms. The altered expression of mRNA for the translation of more glycolytic, fast 
twitch fiber type IIX MHC due to ZH administration suggests that ZH is capable of altering 
protein synthesis; furthermore ZH may decrease the amount of mRNA available for translation 
of the more oxidative, slower fiber type IIA of MHC. 
General Conclusion 
These results indicate that ZH improved animal performance and increased lean tissue 
accumulation in finishing steers. When the steroidal implant RS was administered in finishing 
steers prior to inclusion of ZH in the diet, there were additive improvements on performance and 
lean carcass characteristics. In addition, there was an increase in the expression of β2-AR mRNA 
due to ZH administration. Finally, ZH feeding elicited a differential response in the mRNA 
abundance of MHC by causing a transition away from slower fiber types and increasing faster 
fiber types, which could be a consequence of altered protein synthesis and degradation in bovine 
skeletal muscle. 
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Figures and Tables 
 
Figure 2.1. β1-Adrenergic receptor (β1-AR) mRNA abundance in bovine semimembranosus 
muscle collected from steers 10 min post-slaughter. Four animals per pen were used in the 
analysis (6 pens/treatment). Treatments consist of 1) control (CON), 2) zilpaterol 
hydrochloride (ZH; 8.38 mg/kg), 3) Revalor-S (RS; 120 mg TBA and 24 mg E2), or 4) ZH 
and RS (ZH+RS). There was no main effect or interaction of treatments on the expression 
of β1-AR mRNA. Error bars are SEM. 
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Figure 2.2. β2-Adrenergic receptor (β2-AR) mRNA abundance in bovine semimembranosus 
muscle collected from feedlot steers 10 min post-slaughter. Four animals per pen were used 
in the analysis (6 pens/treatment). Treatments consist of 1) control (CON), 2) zilpaterol 
hydrochloride (ZH; 8.38 mg/kg), 3) Revalor-S (RS; 120 mg TBA and 24 mg E2), or 4) ZH 
and RS (ZH+RS). There was no interaction of treatments on the expression of β2-AR 
mRNA. The main effect of ZH administration increased (P = 0.01) the expression of β2-AR 
mRNA, but there was no effect due to RS administration. Error bars are SEM. 
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Figure 2.3. Calpastatin mRNA abundance in bovine semimembranosus muscle collected 
from feedlot steers 10 min post-slaughter. Four animals per pen were used in the analysis 
(6 pens/treatment). Treatments consist of 1) control (CON), 2) zilpaterol hydrochloride 
(ZH; 8.38 mg/kg), 3) Revalor-S (RS; 120 mg TBA and 24 mg E2), or 4) ZH and RS 
(ZH+RS). There was no main effect or interaction of treatments on the expression of 
calpastatin mRNA. Error bars are SEM. 
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Figure 2.4. Type I myosin heavy chain (MHC-I) mRNA abundance in bovine 
semimembranosus muscle collected from feedlot steers 10 min post-slaughter. Four 
animals per pen were used in the analysis (6 pens/treatment). Treatments consist of 1) 
control (CON), 2) zilpaterol hydrochloride (ZH; 8.38 mg/kg), 3) Revalor-S (RS; 120 mg 
TBA and 24 mg E2), or 4) ZH and RS (ZH+RS). There was no main effect or interaction of 
treatments on the expression of MHC-I mRNA. Error bars are SEM. 
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Figure 2.5. Type IIA myosin heavy chain (MHC-IIA) mRNA abundance in bovine 
semimembranosus muscle collected from feedlot steers 10 min post-slaughter. Four 
animals per pen were used in the analysis (6 pens/treatment). Treatments consist of 1) 
control (CON), 2) zilpaterol hydrochloride (ZH; 8.38 mg/kg), 3) Revalor-S (RS; 120 mg 
TBA and 24 mg E2), or 4) ZH and RS (ZH+RS). There was no interaction of treatment on 
the expression of MHC-IIA mRNA. There was a tendency for RS to increase (P = 0.08), 
and a tendency for the ZH to decrease (P = 0.08) the expression of MHC-IIA mRNA. Error 
bars are SEM. 
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Figure 2.6. Type IIX myosin heavy chain (MHC-IIX) gene expression in bovine 
semimembranosus muscle collected from feedlot steers 10 min post-slaughter. Four 
animals per pen were used in the analysis (6 pens/treatment). Treatments consist of 1) 
control (CON), 2) zilpaterol hydrochloride (ZH; 8.38 mg/kg), 3) Revalor-S (RS; 120 mg 
TBA and 24 mg E2), or 4) ZH and RS (ZH+RS). There was no interaction of treatment on 
the expression of MHC-IIX mRNA. Administration of ZH increased (P < 0.01) the 
expression of MHC-IIX mRNA for the ZH and the ZH+RS treatments; however there was 
no effect of RS administration. Error bars are SEM. 
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Table 2.1 Composition and analyzed nutrient content (DM basis) of the finishing diet1 
 Treatments1
Item Control 2 ZH 3 
Flaked corn 27.55 27.55 
High moisture corn 20.00 20.00 
Wet corn gluten feed 25.00 25.00 
Tallow 2.95 2.95 
Corn silage 19.60 19.60 
Finisher supplement4 3.65 3.65 
Control microingredients5 1.25 - 
ZH microingredients6 - 1.25 
   
Nutrient levels, DM basis 
DM, % 62.46 62.46 
CP, % 12.87 12.87 
NPN, % 1.52 1.52 
ME, Mcal/kg 3.37 3.37 
NDF, % 18.99 18.99 
Calcium, % 0.72 0.72 
Phosphorus, % 0.46 0.46 
1Diets represent feed for the last 33 d on feed; from the start of the zilpaterol-HCl (ZH) 
administration until harvest. 
2Treatments not receiving ZH inclusion in the diet. 
3Treatment receiving ZH inclusion in the diet. 
4The finisher supplements contained (DM basis): 58.43% wheat middlings; 7.25% urea; 5.35% 
salt; 27.20% limestone; 0.50% choice white grease; 0.07% vitamin premix; and 1.20% trace 
mineral premix. 
5Added at the time of diet preparation to provide monensin at 30.86 mg/kg of diet DM and 
tylosin at 9.70 mg/kg of diet DM. 
6Added at the time of diet preparation to provide zilpaterol hydrochloride at 8.38 mg/kg of diet 
DM. 
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Table 2.2 Sequences for bovine-specific PCR primers and Taqman probes for β1- and β2-
adrenergic receptors; calpastatin; types I, IIA, and IIX myosin heavy chain mRNA; and 
RPS9. 
Item  Sequence (5’ to 3’)  
β1-adrenergic receptor (accession no. AF188187)  
Forward  GTGGGACCGCTGGGAGTAT  
Reverse  TGACACACAGGGTCTCAATGC  
TaqMan probe  6FAM-CTCCTTCTTCTGCGAGCTCTGGACCTC-TAMRA  
β2-adrenergic receptor (accession no. NM_174231)  
Forward  CAGCTCCAGAAGATCGACAAATC  
Reverse  CTGCTCCACTTGACTGACGTTT  
TaqMan probe  6FAM-AGGGCCGCTTCCATGCCC-TAMRA  
Calpastatin (accession no. X67333)  
Forward  CCCTGGATCAACTTTCTGACAGT  
Reverse  TGACTTTATCCTCTACAGGTTTATTCTCA  
TaqMan probe  6FAM-TCGGGCAAAGACAGCCTGATCCA-TAMRA  
MHC I (accession no. AB059400)  
Forward  CCCACTTCTCCCTGATCCACTAC 
Reverse  TTGAGCGGGTCTTTGTTTTTCT 
TaqMan probe  6FAM-CCGGCACGGTGGACTACAACATCATAG-TAMRA  
MHC IIA (accession no. AB059398)  
Forward  CCCCGCCCCACATCTT  
Reverse TCTCCGGTGATCAGGATTGAC  
TaqMan probe  6FAM-TCTCTGACAACGCCTATCAGTTCAT-TAMRA  
MHC IIX (accession no. AB059399) 
Forward GGCCCACTTCTCCCTCATTC 
Reverse CCGACCACCGTCTCATTCA 
Taqman probe 6FAM-CGGGCACTGTGGACTACAACATTACT-TAMRA 
RPS9 (accession no. DT860044)  
Forward GAGCTGGGTTTGTCGCAAAA 
Reverse GGTCGAGGCGGGACTTCT 
Taqman probe 6FAM-ATGTGACCCCGCGGAGACCCTTC-TAMRA 
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Table 2.3 Effects of implanting with Revalor-S (RS) and feeding zilpaterol-HCl (ZH; fed 
for the final 30 d on feed plus a 3 d withdrawal) on performance during the final 91 d on 
feed by finishing steers 
 No ZH  ZH1  P-value 
Item No RS RS2  NO RS RS2 SEM3 RS ZH RS x ZH
Initial BW, kg 426.1 426.5  426.0 426.2 6.37 0.72 0.84 0.91 
Final BW, kg 589.6 603.6  600.2 614.0 9.23 <0.01 <0.01 0.96 
ADG4, kg 1.81 1.96  1.92 2.07 0.083 <0.01 <0.01 1.00 
DMI, kg/d 10.31 10.54  10.21 10.44 0.269 0.02 0.27 0.99 
G:F5 0.176 0.186  0.188 0.198 0.0036 <0.01 <0.01 0.63 
HCW, kg 371.1 382.2  392.6 402.6 5.97 <0.01 <0.01 0.60 
Dressing 
percentage 
62.94 63.31  65.42 65.57 0.139 0.05 <0.01 0.38 
LM area, cm2 90.1 94.8  101.7 107.0 1.28 <0.01 <0.01 0.66 
12th rib fat 
depth, cm 
1.52 1.50  1.40 1.35 0.033 0.31 <0.01 0.78 
Marbling 
score5 
369.5 353.4  339.9 323.5 6.53 <0.01 <0.01 0.96 
KPH, % 2.16 2.09  2.02 1.90 0.066 <0.01 <0.01 0.15 
1Zilpaterol-HCl (ZH) inclusion in the diet (8.38 mg/kg of feed on a DM basis) for the last 30 
days of feed with a 3-d withdrawal. 
2Revalor-S (RS) implantation (120 mg TBA and 24 mg E2) 91 d before harvest. 
3Pooled SEM of simple-effect means n = 6 pens/treatment with 90 to 100 steers/pen initially and 
89 to 100 steers/pen at harvest. 
4A 4% shrink was applied to initial and final live weights; dead or removed animals did not 
contribute to initial or final BW. 
5300 = Slight; 400 = Small; 500 = Modest. 
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 CHAPTER 3 - Effects of trenbolone acetate (TBA), estradiol-17β 
(E2), and combined TBA/E2 implants on the levels of myosin heavy 
chain mRNA in skeletal muscle of feedlot steers. 
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Abstract 
Twenty crossbred yearling steers (421 kg) were used to evaluate the effects of implanting 
with trenbolone acetate (TBA), estradiol-17β (E2), and the combination of TBA and E2 on 
finishing steer performance and myosin heavy chain (MHC) mRNA concentrations. Animals 
were blocked by BW, and within each block, assigned to 4 treatments. Animals were housed and 
fed in individual pens. Treatments consisted of: 1) no implant (CON); or implantation with 2) 
TBA (120 mg), 3) E2 (25.7 mg), and 4) combined implant (120 mg TBA and 24.0 mg E2; 
TBA/E2). There were 5 animals per treatment. All animals were weighed weekly, and muscle 
biopsy samples were taken from the LM of each steer on d 0 (prior to implantation), d 7, d 14, 
and d 28. Total RNA was isolated from each sample and real-time PCR was used to measure the 
quantity of the 3 isoforms of bovine MHC mRNA. Total BW gain from the 28-d period was 
adjusted to d 0 by use of covariant analysis, and there was a tendency (P = 0.09) for implant to 
increase weight gain over CON steers. Analysis of the gene expression of MHC showed that 
neither implant nor day had a significant effect on the expression of type-I or -IIX MHC mRNA. 
There was also no treatment effect on MHC-IIA, but increasing days on feed increased (P = 
0.05) the expression of MHC-IIA mRNA. Results of this study indicate that implanting with 
TBA, E2, or both increased BW gain of finishing steers without significantly affecting the 
concentration of type-I, -IIA, or -IIX MHC mRNA. Increasing days on feed increased the levels 
of MHC-IIA in bovine skeletal muscle. We conclude that administration of steroidal implants 
has no effect on the proportion of the 3 different MHC mRNA isoforms in bovine skeletal 
muscle. 
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Introduction 
 It is well established that administration of anabolic steroid hormones improves the rate 
of lean growth in beef animals (Bartle et al., 1992; Hayden et al., 1992; Samber et al., 1996; 
Birkelo et al., 2003; Platter et al., 2003). In 1992, the FDA approved the use of implants 
containing the combination of androgenic and estrogenic steroids. Beef steers implanted with the 
combination of trenbolone acetate (TBA) and estradiol-17β (E2) have increased ADG, G:F, and 
LM area, without changes in DMI (Johnson et al., 1996; Pampusch et al., 2003). Though the 
improved performance associated with the combined implant is well documented and accepted, 
the processes by which these results are obtained are not so well understood. Satellite cells play a 
key role in postnatal skeletal muscle growth by contributing necessary DNA for tissue fiber 
hypertrophy (Allen et al., 1979). Hormone implants are thought to elicit biological responses in 
skeletal muscle by increasing protein synthesis and decreasing protein degradation. It is thought 
that protein synthesis and subsequent skeletal muscle hypertrophy of implanted cattle may be 
due in part to anabolic steroid hormones affecting the activation of quiescent satellite cells 
(Johnson 1998). One way to evaluate changes in protein synthesis and degradation is through 
measuring the gene expression of major proteins that are synthesized in skeletal muscle. Myosin 
is an important part of the contractile machinery in bovine skeletal muscle, and it exists in 3 
isoforms (type-I, -IIA, and -IIX) which contribute to the functional diversity of muscle fibers 
(Pette and Staron, 2000). In the bovine species the MHC-IIB isoform has not been detected in 
skeletal muscle (Chikuni et al., 2004; Toniolo et al., 2005). Muscle hypertrophy results in an 
increase in the relative diameter of muscle fibers. The faster twitch, more glycolytic myosin 
isoforms have larger fiber diameter and exist in higher frequencies in muscle that experience the 
greatest amount of muscle hypertrophy in growing animals (Gunawan et al., 2007a). Transitions 
of fiber type in muscle can be used to show that gene expression of a fully differentiated 
postmitotic cell can be altered by hormonal factors and age (Pette and Staron, 2000). Hormonal 
differences, especially testosterone, may contribute to the gender differences in specific fiber 
type sizes that ultimately affect the relative concentration of MHC isoforms (Staron et al., 2000). 
Differences in fiber type have also been associated with meat quality in pigs (Sosnicki et al., 
1987; Chang et al., 2003). Changes in the fiber type of MHC indicate potential alterations in 
protein synthesis, degradation, or both. Currently, there is little information published on the in 
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vivo effects of TBA and E2 on skeletal muscle fiber type of MHC mRNA in finishing steers. The 
purpose of this study was to investigate the effects of TBA and E2 on skeletal muscle MHC 
mRNA abundance. 
Materials and Methods 
Animals.  
All experimental procedures were approved by the Kansas State University Institutional 
Animal Care and Use Committee, and performed at the Kansas State University Beef Cattle 
Research Center. Twenty yearling crossbred steers with an average initial BW of 421 ± 3.6 kg 
were blocked by BW and randomly assigned within block, in a 2 x 2 factorial arrangement, to 4 
treatments: 1) no implant (CON), 2) implant with 25.7 mg estadiol-17β (Compudose, Vetlife 
Inc., West Des Moines, IA; E2); 3) implant with 120 mg of trenbolone acetate (Finaplix, Intervet 
Inc., Millsboro, DE; TBA), 4) implant with 120 mg TBA and 24 mg E2 (Revalor-S, Intervet Inc., 
Millsboro, DE; TBA/E2). On 21 d before implant, all animals were placed in individual feeding 
stalls and transitioned onto a 93% concentrate diet and offered feed for ad libitum intake 
throughout the study (Table 3.1). All steers were consuming the 93% concentrate diet on d 0. A 
single implant was administered subcutaneously in the right ear on d 0, after biopsy procedures, 
to appropriate treatment groups with the CON group receiving no implant. The live BW of each 
steer was measured on d 0, d 7, d 14, and d 28, prior to biopsy procedure, for analysis of 
performance. 
Longissimus Muscle Biopsy. 
 Biopsy samples of the LM (1.0 g) were collected between the 10th and 13th rib from all 
steers before implant on d 0, and subsequently at d 7, 14, and 28.  Briefly, steers were restrained 
in a hydraulic squeeze chute, hair was removed from the biopsy site and a local anesthetic 
(lidocaine HCl; 20 mg/mL; 8 mL per biopsy site) was administered.  Biopsy site was cleaned 
with 70% ethanol and sterile surgical gauze.  A 1-cm incision was made with a sterile scalpel. 
Tissue was collected from the LM utilizing a sterile Bergstrom biopsy needle.  The incision site 
was closed with veterinary tissue glue. A topical antibiotic spray was applied to the incision site 
and then covered with a spray-on aluminum bandage. All steers were monitored for swelling 24 
and 48 h after biopsy. Samples were obtained on alternate sides of the animal relative to the 
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previous collection, and the third and fourth biopsy samples were obtained 5 cm anterior to 
previous biopsy locations. 
Sample Preparation and RNA Isolation.  
Muscle biopsy samples from each steer were placed in 10 mL of a 5 M guanidine 
thiocyanate, 50 mM Tris-HC1, 25 mM EDTA, 0.5% lauryl sarcosine, and 1% β-mercaptoethanol 
solution in polypropylene tubes. Samples were homogenized, rapidly frozen in liquid N2, and 
stored at -80°C for subsequent RNA isolation (Chomczynski and Sacchi, 1987). The RNA was 
mixed with one half volume LiCl precipitation solution (7.5 M LiCl, Ambion, Austin, TX) and 
incubated at -20°C for 30 min. The solution was then centrifuged at high speed in a 
microcentrifuge for 15 min. The resulting pellet was washed with 70% ethanol, dried, and 
resuspended in water. Samples were treated with DNase (DNA-Free, Ambion, Austin, TX) to 
remove any contaminating genomic DNA. The RNA concentration was determined by 
absorbance at 260 nm. The integrity of the RNA was determined by electrophoresis of total RNA 
through a 1% agarose-formaldehyde gel followed by ethidium bromide staining to allow 
visualization of 28 and 18S ribosomal RNA (rRNA). The RNA was then reverse transcribed to 
produce first-strand complimentary DNA (cDNA) as described below. 
Real-Time Quantitative PCR.  
Real-time quantitative PCR was used to measure MHC-I, MHC-IIA, and MHC-IIX 
mRNA gene expression relative to the quantity of ribosomal 18S (18S) in total RNA isolated 
from muscle tissue. Measurements of the relative quantity of cDNA was performed by using 
TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA), 900 nM of the 
appropriate forward and reverse primers, 200 nM of the appropriate TaqMan detection probe, 
and 1 μL of the cDNA mixture. The bovine-specific MHC-I, MHC-IIA, and MHC-IIX forward 
and reverse primers and TaqMan detection probes (Table 3.2) were synthesized by using 
published GenBank sequences. Commercially available eukaryotic 18S rRNA primers and 
probes were used as an endogenous control (Applied Biosystems, Foster City, CA; Genbank 
Accession No. X03205). The ABI Prism 7000 detection system (Applied Biosystems, Foster 
City, CA) was used to perform the assay by using the recommended thermal cycling variables 
from the manufacturer (50 cycles of 15 s at 95˚C and 1 min at 60˚C). The 18S rRNA endogenous 
control was used to normalize the expression of MHC-I, MHC-IIA, and MHC-IIB isoforms.  
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Statistical Analysis.  
Data were analyzed as a 2 x 2 factorial arrangement of treatments in a randomized 
complete block design with PROC MIXED procedure in SAS for Windows release 9.1 (SAS 
Inst. Inc., Cary, NC). Steers were blocked by weight, and animal served as experimental unit for 
all statistical analysis. Main effect and interaction means were separated (P < 0.05) with the LSD 
procedure of SAS. 
Results and Discussion 
Performance.  
The performance data is shown in Table 2.3. The average initial BW (421 + 3.6 kg) of all 
treatment groups did not differ on d 0. The final BW of the implanted groups tended (P < 0.10) 
to be greater than CON steers. There was a treatment by day interaction (P < 0.05) as BW of 
steers implanted with only TBA was greater than CON steers by d 14 (P < 0.05), and on d 28 all 
implanted groups were heavier than CON steers (P < 0.05). Dry matter intake differences among 
treatment groups were numerically large enough to be biologically important, however, these 
differences were not significant. These results support similar studies with steers administered 
TBA and E2, which show that implants containing TBA and E2 improve ADG, G:F and the 
deposition of carcass lean tissue (Bartle et al., 1992; Johnson et al., 1996). Another study 
analyzed the effects of TBA, E2, and TBA/E2 in yearling steers and found the deposition of 
skeletal muscle protein was markedly increased within 40 d post-implantation (Hayden et a., 
1992). Our performance results support these findings, but there is a lack of strong statistical 
support, likely due in part to the small number of animals per treatment used in this study. 
Myosin Heavy Chain Gene Expression. 
 In the current study, we analyzed the expressed levels of MHC isoform types I, IIA, and 
IIX mRNA in steer LM tissue by real-time PCR. Data for all gene expression is shown in Figures 
3.1-3.6. There was no treatment, day, or treatment by day interaction on the abundance of MHC-
I (slow-oxidative) in LM tissue of steers. There was no treatment or treatment by day interaction 
on the expression of MHC-IIA, however there was an increase (P = 0.05) in MHC-IIA as days 
on feed increased. No treatment, day, or treatment by day interaction was observed for the 
expression of MHC-IIX. These results indicate that neither TBA, E2, nor the combination of 
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TBA+E2 affect the mRNA expression of MHC-I, -IIA, or -IIX early in the feeding period 
following implantation. However as days on feed increases, there was an increase in the amount 
of MHC-IIA mRNA that is presumably available for the subsequent translation of the MHC-IIA 
protein.  
 To date there have been no studies that have analyzed the effects of anabolic steroid 
implants on the mRNA abundance of MHC isoforms in the LM of finishing steers. There have 
been attempts to determine the effect of anabolic steroids on MHC protein fiber types and size 
through histochemical analysis procedures. Steers administered a Synovex-S implant (20 mg 17-
β estradiol benzoate and 200 mg progesterone) had no effect on the fiber type distribution or area 
in the LM (Ono et al., 1996). Another study showed that implant treatments with Revalor-S, 
Ralgro (zeranol), or Synovex-S had no effect on either percentage of fiber type or the cross 
sectional area of slow-twitch-oxidative, fast-twitch-oxidative-glycolytic, or fast twitch-glycolytic 
fibers in the LM of steers (Fritsche et al., 2000). Gonzalez et al. (2007) found that TBA alone 
had no effect on the percentage, computed cross sectional area, or diameter of type II muscle 
fibers, and no effect on the percentage of type I muscle fibers in the LM of cull beef cows. 
However, TBA did increase cross sectional area and diameter of type I muscle fibers in the LM 
(Gonzalez et al., 2007). These data are similar to the results of our studies that anabolic steroids 
appear to have little effect on MHC mRNA levels. It is important to note that these studies 
measured the distribution of fiber types found in muscle by means of histochemical and immuno-
histochemical analysis, whereas our study analyzed the mRNA abundance of the MHC isoforms 
by real-time PCR in skeletal muscle samples obtained by serial biopsy. 
Gene Expression Overview. 
 Myosin heavy chain isoforms are unique types of protein that research has worked to 
better understand and classify. There have been 4 main isoforms of MHC mRNA detected in 
porcine skeletal muscle, however only 3 of these isoforms have been detected in bovine skeletal 
tissue. In general, type IIB MHC mRNA is not expressed in skeletal muscle of cattle (Chikuni et 
al., 2004; Gonzalez et al., 2007), with the exception being the extraocular muscles which are the 
only skeletal muscles known to express MHC-IIB mRNA in cattle (Toniolo et al., 2005). 
Therefore, we did not analyze the LM tissue for the expression of MHC-IIB mRNA. 
 Muscle fiber types are classified according to functional (slow-twitch vs. fast-twitch) and 
metabolic (glycolytic vs. oxidative) properties as well as radial growth. Previous studies have 
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struggled with accurate correlations between myosin composition and fiber type distribution of 
skeletal muscle. It appears that MHC isoforms are the most appropriate markers for fiber type 
delineation (Pette and Staron, 2000). The 2 factors that have complicated this issue are: 1) a 
continuum of fiber types exist and multiple myosin heavy chains can coexist in the same fiber 
type (Bee et al., 1999), and 2) the molecular identification of fiber types based on MHC 
expression is more precise and reliable than immuno-histochemical staining (Kim et al., 2008). 
With regard to the extraocular muscles in bovine, there is evidence that MHC-IIB is expressed at 
the protein level in those muscles where the corresponding mRNA is present (Toniolo et al., 
2005). Also, the expression of MHC genes was highly correlated with their relative amount of 
the corresponding protein contained within porcine skeletal muscle (Gunawan et al., 2007b). 
Therefore, gene expression of MHC mRNA has been determined to be an appropriate and 
accurate indicator of the amount and type of protein that is translated in skeletal muscle, and was 
the method chosen for the current study. 
 It is well documented that another form of growth promotants know as β-adrenergic 
agonists (β-AA) can alter the expression of MHC. Administration of β-AA causes a shift in the 
amount of isoform expressed from slower, oxidative to faster, glycolytic fiber types, as well as 
dramatically increasing the size of the type IIB fibers (Beermann et al., 1987; Zeman et al., 1988; 
Polla et al., 2001). Both steroid hormones and β-AA have been shown to increase the 
accumulation of lean tissue in skeletal muscle of cattle. Due to the similar nature of response on 
skeletal muscle deposition, we expected to observe similar patterns of change in the gene 
expression of MHC. Interestingly, we did not observe similar results, but rather no effects were 
observed due to treatment of steroid hormones. Steroid hormones and β-AA elicit a similar 
growth response in regard to lean tissue accumulation, but these observations imply that 
responses occur through different pathways. 
 In a previous study with rats administered a high therapeutic dose of nortestosterone over 
a 25-d period, there were no modifications in muscle phenotype (Noirez and Ferry, 2000). These 
results support our observation of the lack of effect from the treatments containing trenbolone. It 
is important to note that different species have variation in type and amount of myosin genes 
expressed, as well as their physiological response to steroid hormones. 
 There are various factors that can affect MHC fiber type transitions, one of which is the 
effect of the mechanical load exerted on the muscle (Pette and Staron, 2000). This could be a 
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possible factor in the change in fiber type observed in our study. The reduction in pen size where 
the animals were housed during our study could have affected the physical activity and 
mechanical load on skeletal muscle; however, this would have a greater impact on skeletal 
muscles of the limbs, rather than a trunk muscle like the LM. Therefore, the impact of physical 
activity and skeletal muscle load on the expression of MHC of the LM muscles would likely be 
minimal, if any at all. Furthermore, all animals were acclimated to the individual pens 21 d 
before starting the study, thus reducing the effect of changes in physical activity. 
 Another factor that is related to variations in MHC isoforms expressed in bovine skeletal 
muscle is meat quality. It has been shown that MHC isoform composition contributes to the 
variations observed in postmortem energy metabolism, susceptibility to adverse pH, temperature 
effects, and ultimately meat quality in porcine muscle (Bowker et al., 2004). Steers that received 
aggressive implant protocols during the finishing stages of development had carcasses that were 
lower in both marbling and tenderness than those of non-implanted steers, and increasing the 
amount of implants a steer receives over its lifetime further reduces marbling and tenderness 
(Platter et al., 2003). Integrating these results with the findings of the current study would imply 
that the gene expression of myosin may not be related to the carcass characteristics of tenderness 
and marbling in beef steers, although we only analyzed changes in MHC over the first 28 d 
following administration of the implants. 
General Conclusion 
 In growing beef steers there are various factors that affect protein synthesis/degradation 
and ultimately lean tissue accumulation. Steroid hormones are compounds that accelerate this 
growth process by pathways that are still not fully understood. An alteration in the gene 
expression of MHC mRNA is one indicator of changes in protein synthesis and degradation. It is 
evident that implants containing TBA and E2 do not alter the mRNA gene expression of MHC 
isoforms during the first part of the feeding period of growing beef steers; however increasing 
the days on feed did increase the abundance of MHC-IIA. 
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Figures and Tables 
 
Figure 3.1. Myosin heavy chain type I mRNA abundance in bovine LM tissue in yearling 
steers collected at 4 different biopsy days. Treatments included: 1) no implant (CON); or 
implant with 2) 25.7 mg estradiol-17β (E2); 3) 120 mg trenbolone acetate (TBA); and 4) 
combined implant of 120 mg trenbolone acetate and 24 mg estradiol-17β; (TBA/E2). 
Biopsies were taken from 5 steers in each of the 4 treatment groups. Biopsy samples were 
collected on d 0, 7, 14, and 28 after administration with steroidal implant. Total RNA was 
isolated from skeletal muscle tissue and relative MHC-I gene expression was determined 
using real-time quantitative-PCR. There were no effects due to treatments on the 
expression of MHC-I. Error bars are SEM. 
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Figure 3.2. Myosin heavy chain type IIA mRNA abundance in bovine LM tissue in yearling 
steers collected at 4 different biopsy days. Treatments included: 1) no implant (CON); or 
implant with 2) 25.7 mg estradiol-17β (E2); 3) 120 mg trenbolone acetate (TBA); and 4) 
combined implant of 120 mg trenbolone acetate and 24 mg estradiol-17β; (TBA/E2). 
Biopsies were taken from 5 steers in each of the 4 treatment groups. Biopsy samples were 
collected on d 0, 7, 14, and 28 after administration with steroidal implant. Total RNA was 
isolated from skeletal muscle tissue and relative MHC-IIA gene expression was determined 
using real-time quantitative-PCR. There were no effects due to treatments on the 
expression of MHC-IIA. Bars represent standard error within treatments. 
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Figure 3.3. Myosin heavy chain type IIX mRNA abundance in bovine LM tissue in yearling 
steers collected at 4 different biopsy days. Treatments included: 1) no implant (CON); or 
implant with 2) 25.7 mg estradiol-17β (E2); 3) 120 mg trenbolone acetate (TBA); and 4) 
combined implant of 120 mg trenbolone acetate and 24 mg estradiol-17β; (TBA/E2). 
Biopsies were taken from 5 steers in each of the 4 treatment groups. Biopsy samples were 
collected on d 0, 7, 14, and 28 after administration with steroidal implant. Total RNA was 
isolated from skeletal muscle tissue and relative MHC-IIX gene expression was determined 
using real-time quantitative-PCR. There were no effects due to treatments on the 
expression of MHC-IIX. Error bars are SEM. 
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Figure 3.4. Myosin heavy chain type I mRNA abundance in bovine LM tissue in yearling 
steers collected on 4 different biopsy days. Biopsy samples were collected on d 0, 7, 14, and 
28 on feed from 20 individual steers. Total RNA was isolated from skeletal muscle tissue 
and relative MHC-I gene expression was determined using real-time quantitative-PCR. 
There was no effect on the expression of MHC-I with increasing days on feed. Error bars 
are SEM. 
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Figure 3.5. Myosin heavy chain type IIA mRNA abundance in bovine LM tissue in yearling 
steers collected on 4 different biopsy days. Biopsy samples were collected on d 0, 7, 14, and 
28 on feed from 20 individual steers. Total RNA was isolated from skeletal muscle tissue 
and relative MHC-IIA gene expression was determined using real-time quantitative-PCR. 
There was a significant (P < 0.05) increase in the expression of MHC-IIA with increasing 
days on feed. Error bars are SEM. 
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Figure 3.6. Myosin heavy chain type IIX mRNA abundance in bovine LM tissue in yearling 
steers collected on 4 different biopsy days. Biopsy samples were collected on d 0, 7, 14, and 
28 on feed from 20 individual steers. Total RNA was isolated from skeletal muscle tissue 
and relative MHC-IIX gene expression was determined using real-time quantitative-PCR. 
There was no effect on the expression of MHC-IIX with increasing days on feed. Error bars 
are SEM. 
0 7 14 28
0
5
10
15
20
Day
M
H
C
-II
X 
m
R
N
A
,
re
la
tiv
e 
un
its
, t
ho
us
an
ds
 
 72
 Table 3.1. Composition and analyzed nutrient content of the finishing diet 
Item % of DM 
Corn, steam-flaked 78.09 
Alfalfa hay, ground 11.96 
Corn steep liquor 4.31 
Supplement1 3.46 
Rumensin/Tylan premix2 2.18 
  
DM, % 79.71 
CP, % of DM 13.56 
NDF, % of DM 14.47 
NEm, Mcal/lb 2.09 
NEg, Mcal/lb 1.42 
1The supplement contained (DM basis): 45.29% limestone, 35.20% urea, 8.69% salt, 
7.28% potassium, 1.45% vitamin E (20,000 IU/g), 1.28% trace mineral premix (3.67 
mg/kg Co, 291.15 mg/kg Cu, 18.21 mg/kg iodineum, 1747.83 mg/kg Mn, 7.28 mg/kg Se, 
1745.90 mg/kg Zn), 0.60% sodium selenium, and 0.21% vitamin A (30,000 IU/g) 
2Rumensin/Tylan premix contained (DM basis): 97.30% dry rolled corn, 1.50% soybean 
oil, 0.75% Rumensin (1480 mg/kg; Elanco Animal Health, Indianapolis, IN), and 0.45% 
Tylan (445 mg/kg; Elanco Animal Health, Indianapolis, IN) 
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Table 3.2. Sequences for bovine-specific PCR primers and Taqman probes of type I, IIA, 
and IIX myosin heavy chain (MHC) mRNA. 
Item  Sequence (5’ to 3’)  
MHC I (accession no. AB059400)  
Forward  CCCACTTCTCCCTGATCCACTAC 
Reverse  TTGAGCGGGTCTTTGTTTTTCT 
TaqMan probe  6FAM-CCGGCACGGTGGACTACAACATCATAG-TAMRA  
MHC IIA (accession no. AB059398)  
Forward  CCCCGCCCCACATCTT  
Reverse TCTCCGGTGATCAGGATTGAC  
TaqMan probe  6FAM-TCTCTGACAACGCCTATCAGTTCAT-TAMRA  
MHC IIX (accession no. AB059399) 
Forward GGCCCACTTCTCCCTCATTC 
Reverse CCGACCACCGTCTCATTCA 
Taqman probe 6FAM-CGGGCACTGTGGACTACAACATTACT-TAMRA 
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Table 3.3. Cumulative performance by treatment 
 Implant dose (E2:TBA), mg  
Item 0:0 25.7:0 0:120 24:120 SEM1 
No. of observations 4 5 5 5 -- 
Initial BW, kg 419.1 417.8 421.8 421.8 2.94 
0 to 14 d      
BW, kg 438.6 444.1 452.7 444.5 4.08 
ADG, kg 1.39 1.89 2.21 1.62 0.232 
DMI, kg 7.96 8.77 9.19 8.13 0.416 
      
15 to 28 d      
BW, kg 450.0 464.5 467.7 469.9 5.53 
ADG, kg 0.81 1.48 1.07 1.81 0.271 
DMI, kg 7.33 8.95 9.03 8.39 0.486 
      
0 to 28 d      
BW gained, kg 30.9 46.7 45.9 48.1 5.53 
ADG, kg 1.10 1.67 1.64 1.72 0.197 
DMI, kg 7.65 8.86 9.11 8.26 0.411 
G/F 0.144 0.188 0.180 0.208 0.015 
1Calculated using 5 observations per treatment 
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